Bayer HealthCare AG Gets Positive Phase 2 Data For Antithrombosis Drug
FRANKFURT, June 12 (Reuters) - Bayer (BAYG.DE: Quote, Profile, Research) has received positive clinical data for its antithrombosis drug BAY 59-7939, the German drugmaker said on Monday.